exposure, confounding, and outcome variables. In addition to evaluating main exposure-disease associations, analyses are also conducted to evaluate whether exposure-disease associations are modified by other dietary and nondietary factors or vary among population subgroups or particular cancer subtypes. Study-specific relative risks are calculated using the Cox proportional hazards model and then pooled using a random-or mixed-effects model. The study-specific estimates are weighted by the inverse of their variances in forming summary estimates. Most of the methods used in the Pooling Project may be adapted for examining associations with dietary and nondietary factors in pooled analyses of case-control studies or case-control and cohort studies combined. cohort studies; diet; epidemiologic methods; meta-analysis; neoplasms
The growing number of epidemiologic publications on the relation between diet and cancer risk has heightened the need for methods of summarizing results from multiple studies. These methods include qualitative reviews and quantitative summaries such as meta-analyses of the published literature and pooled analyses of the primary data (also called meta-analyses of individual data) (1) . A general framework for conducting pooled analyses entails 1) formulating study inclusion criteria; 2) identifying all potential studies meeting these criteria; 3) obtaining each study's primary data; 4) creating a standardized database; 5) estimating study-specific exposure-disease associations; 6) examining whether the study-specific results are heterogeneous; 7) calculating pooled estimates, if applicable; and 8) conducting sensitivity analyses to evaluate whether the estimates are robust (2) . There are many advantages to reanalyzing the primary data from multiple studies rather than extracting the study-specific relative risks from published articles (1) (2) (3) (4) (5) . In a pooled analysis, the modeling of the exposure, confounding, and outcome variables, the choice of which variables to control for, and the type of analysis conducted can be standardized, thereby removing potential sources of heterogeneity across studies. Because of larger sample sizes, pooled analyses also offer investigators the opportunity to examine uncommon exposures, rare diseases, and variation in associations among population subgroups with greater statistical power than is possible in individual studies.
The pooling of data from observational studies has become more common recently (6) (7) (8) (9) (10) (11) (12) (13) . Summary estimates have been calculated using a weighted average of the study-specific estimates (8, 9, 11) or by combining studies into a single data set for the analysis (6, 7, 10, 12, 13) . In this paper, we describe the methods that are being used within the ongoing Pooling Project of Prospective Studies of Diet and Cancer (the Pooling Project), an international consortium of cohort studies with the goal of providing the best available summary of data on associations between diet and cancer (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . Most of these methods can also be adapted to examine associations in pooled analyses of case-control studies or both case-control and cohort studies combined.
INCLUSION CRITERIA
To maximize the quality and comparability of the studies in the Pooling Project, we formulated several inclusion criteria a priori. First, we include prospective studies which 1) had at least one publication on the relation between diet and cancer; 2) used a dietary assessment method that was of sufficient detail to calculate intakes of most nutrients, including energy, and that assessed intake over a period of months or years; and 3) assessed the validity of their dietary assessment method or a closely related instrument. Second, for each cancer site evaluated, we specify a minimum number of cases required for a study to be included in the analysis. Additional inclusion criteria also may be made for each cancer site. Third, for each analysis, we include only those studies that assessed the specified exposure and in which participants consumed the dietary item of interest. For analyses that are going on simultaneously in the Pooling Project and the European Prospective Investigation into Cancer and Nutrition (31), we intend to coordinate analyses so that, to the extent possible, we can use similar analytic approaches and provide comparable results.
COMPONENT STUDIES
Sixteen studies (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) are currently included in the Pooling Project (table 1) . As we become aware of new studies meeting the inclusion criteria, the investigators from those studies are invited to join the Project. The Canadian National Breast Screening Study and the Netherlands Cohort Study are each analyzed as case-cohort studies (47) , because the investigators in these two studies each selected a random sample of the cohort to provide the person-time data for the cohort and have processed questionnaires for only this random sample and the cases. We divide the persontime and numbers of cases compiled during follow-up of the Nurses' Health Study into two segments to take advantage of the expanded food frequency questionnaire administered in 1986 as compared with 1980. In this paper, we refer to the follow-up period from 1980 to 1986 as ''Nurses' Health Study A''; the follow-up period beginning in 1986 is referred to as ''Nurses' Health Study B.'' Following standard survival data analysis theory, blocks of persontime in different time periods are asymptotically uncorrelated, regardless of the extent to which they are derived from the same people (48, 49) . Thus, pooling of the estimates from these two time periods produces estimates and standard errors which are as valid as those from a single time period.
the data for completeness and resolve inconsistencies with the investigators of each study.
Each study used a food frequency questionnaire or diet history instrument that was designed and pretested in its specific study population or a similar population (P. L. HornRoss, unpublished data; V. Krogh, unpublished data; A. Wolk, unpublished data) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (table 1) . Although the numbers of items included in the food frequency questionnaires varied over fivefold across the studies (table 1) , the study-specific correlation coefficients comparing the food frequency questionnaire used in each cohort or a closely related instrument with multiple dietary records or 24-hour recalls generally exceed 0.40 for total fat, dietary fiber, and several micronutrients (P. L. Horn-Ross, unpublished data; V. Krogh, unpublished data; A. Wolk, unpublished data) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (table 2) .
Information on nondietary risk factors was collected at baseline in each study using self-administered questionnaires. For measured covariates, the proportion of missing data for nondietary risk factors is generally low across studies (table 3) . The exception is the Swedish Mammography Cohort, in which some covariate information was available for only one of the two counties in the study.
Case ascertainment
Incident cancer diagnoses are identified through followup questionnaires, with subsequent medical record review (37, 44, 46) , linkage with cancer registries (32, 36, (39) (40) (41) (42) 45) , or both (33-35, 38, 43) . In addition, investigators in some studies ascertain incident and/or fatal outcomes using mortality registries (32, 34, 35, (37) (38) (39) (41) (42) (43) (44) (45) (46) . Case ascertainment has generally been estimated to be greater than 90 percent in each study (table 1) .
STATISTICAL APPROACHES AND RATIONALE
For each cohort, after applying the exclusion criteria used in that study, we further exclude participants who reported log e -transformed energy intakes beyond three standard deviations from the study-specific log e -transformed mean energy intake of the baseline population (or subcohort, for the case-cohort studies) or who reported a history of cancer (except nonmelanoma skin cancer) at baseline. Additional exclusion criteria may be applied for analyses of specific cancer sites. Because many cancers appear to have hormonal antecedents and because lifestyle factors may differ between women and men, studies including both women and men are split into two studies: a cohort of women and a cohort of men. This conservative approach, in which all estimates are calculated separately for women and men in those studies including both genders, allows for potential effect modification by sex for every determinant of the outcome.
Follow-up time is calculated for each participant from the date on which his/her baseline questionnaire was returned to the date of diagnosis of the specific cancer being examined, the date of death, the date on which the participant moves out of the study area (if applicable), or the end of follow-up, whichever comes first.
In our analyses, we create standardized categories for most confounding variables across studies. We create a missing-data indicator variable for missing responses for each measured confounder in a study, if applicable. As long as 1) the association between the confounding variable and the exposure of interest is weak, or the association between the confounding variable and the outcome is weak, or the confounding variable has little variability in the study and 2) the percentage of missing data within the study is low, the use of the missing-data indicator method is likely to improve efficiency without introducing appreciable bias in comparison with the complete case method (60, 61) . As table 3 shows, the proportion of missing data for each covariate across studies is generally low, satisfying one of the conditions for valid use of the missing-data indicator method. In addition, potentially confounding factors generally have had moderate-to-weak associations with the cancer sites we have examined and have had low-to-moderate correlations with the dietary exposures that are of primary interest in the Pooling Project. Information on age, which is typically the strongest measured risk factor for cancer incidence, is never missing in the constituent studies.
Two-stage analysis
Our analytic approach generally is a two-stage process. In the first step, we calculate study-specific relative risks using the Cox proportional hazards model (49) , defined through the hazard function h by
for s ¼ 1, . . ., S, where s is the study number, t is follow-up time, u is and x is are the study-specific confounding and exposure variables, respectively, for individual i in study s, and h 0jks (t) is the baseline incidence rate at age j (in years), in calendar year k, and for time since entry into the study t. The estimated study-specific log relative risks for a one-unit increase in the exposures, x is , are given by the b s . The studyspecific log relative risks for a one-unit increase in the confounding variables, u is , are given by the a s . Stratifying jointly by age at baseline (years) and the year in which the baseline questionnaire was returned (indexed by j and k, respectively) and treating follow-up time (in years) as the time metric in the Cox model is equivalent to treating age as the time metric in the Cox model and stratifying jointly on calendar time (in years) and duration of time in the study, with one exception: There is a difference in which two-way interactions are allowed. With our approach, no assumptions are made about the shape of the age or calendar-year incidence curves, each of which is fully adjusted for the other, and arbitrary two-way interactions of the joint dependency of the outcome on age and calendar time are allowed. Each case-cohort study is analyzed using EPICURE software (HiroSoft International Corporation, Seattle, Washington) (47, 62) ; each remaining study is analyzed using SAS PROC PHREG (SAS Institute, Inc., Cary, North Carolina) (63) . If case-control studies were included in our pooled analyses, the model for these studies would be similar to equation 1, except that we would stratify the participants by (42) were identified through linkage with a cancer registry; thus, it is difficult to determine the follow-up rate in the cohort. When a subset of the cohort was followed intensively, loss to follow-up was not related to exposure. study-specific matching factors. Since the Cox model and the conditional logistic regression model produce algebraically identical log-(partial)-likelihood functions, SAS PROC PHREG could also be used for case-control studies to estimate study-specific odd ratios and their standard errors. The second step consists of pooling the study-specific relative risks using a random-effects model (64-66) given bŷ
where theb s are the estimated study-specific exposuredisease effects, b is the underlying common exposuredisease association, b s are the random between-studies effects, and e s are the within-study errors. Both b s and e s are assumed to be independent and asymptotically normally distributed with means of zero and variances of r (66, 67) . For the exposures of interest, we generally categorize participants into study-specific quantiles. Because the quantile approach does not take into account true differences in the distribution of population intakes across studies, we also create categories defined by identical absolute intake cutpoints across studies. Misclassification can also occur in the analyses based on identical absolute intake cutpoints, because reported intakes may differ across studies based on differences in the dietary assessment methods used. However, when possible we adjust our results for measurement error in the individual studies.
Aggregated analysis
We can also conduct analyses in which the data from all studies are combined into one data set (referred to as an aggregated analysis). A single exposure-disease effect is then calculated using the Cox proportional hazards model, including stratification by study, age at baseline, and the year in which the baseline questionnaire was returned. Although combining the data from all studies is one way to take advantage of differences in the distributions of the exposure variable across studies, it assumes that the exposure was measured in comparable ways across studies. Because the distributions of dietary variables may differ across studies due to true differences in actual intake and due to differences in the dietary assessment methods used (and other study-specific sources of error), this assumption may not be reasonable, except for nutrients that come from a small number of food sources (e.g., alcohol). In addition, combining the studies into one data set assumes that there is no between-studies heterogeneity in the associations of the outcome with the exposure or any of the covariates. In the few instances where we have conducted both pooled and aggregated analyses, the results have been essentially identical (16, 25, 30) . Nevertheless, because it is difficult to test the underlying assumptions, we have opted to use two-stage analyses as our primary analytic strategy.
Trend analysis
To test the significance of trends in disease risk over exposure categories, we conduct separate analyses in which participants are assigned the study-specific median value of their respective category (given by med js for j ¼ 1, . . ., J, where J is the number of levels in which the exposure variable is categorized). For each study, we fit a Cox proportional hazards model with regression terms b s z is for s ¼ 1, . . ., S, where s is the study number and z is takes on the values med js corresponding to the category in which the individual's exposure value falls. We then compute the pooled estimate for the regression coefficient for trend using a random-effects model (64) (65) (66) . The pooled test for trend is a Wald test of the hypothesis H 0 : b ¼ 0. We test for the statistical significance of between-studies heterogeneity among the study-specific regression coefficients using the Q test statistic (66, 67) .
We also evaluate whether associations between dietary factors and cancer risk are linear by comparing nonparametric regression curves using restricted cubic splines with the linear model using the likelihood ratio test, and by visual inspection of the restricted cubic spline graphs (68, 69) . For these analyses, the studies are combined into a single data set stratified by study.
Evaluation of heterogeneity of effects
An advantage of a pooled analysis is the ability to evaluate whether the exposure-disease association is modified by other risk factors. In these analyses, if the exposuredisease association is log-linear and the potential effect modifier is an ordinal or binary variable, we first compute estimates of the exposure-disease association and their standard errors for each study within each category of the [1980] [1981] [1982] [1983] [1984] [1985] [1986] and Nurses' Health Study B (1986-present) were counted as two separate studies (see Materials and Methods).
y All participants in the California Teachers Study, the Health Professionals Follow-up Study, the Nurses' Health Study, and Nurses' Health Study II were assumed to have received additional education after graduating from high school, because these populations were selected on the basis of their employment in occupations requiring a post-high-school education.
z Only cohort studies including women are included here. The prevalence of missing data was calculated only among the female participants.
§ For the Swedish Mammography Cohort, only the percentage of missing data for women living in Uppsala County is included, since these data were not collected for women living in Vastmanland County.
{ Among postmenopausal women only.
potential effect modifier. The model uses the same format as equation 1, but
where l ¼ 1, . . ., L levels of the effect modifier, x is is the study-specific exposure variable, and a sl are the estimated study-specific log relative risks for a one-unit increase in the confounding variables, u is . The study-specific estimatesb sl for each stratum are then pooled across studies and exponentiated to obtain the relative risk for each level of the potential effect modifier. For assessment of the statistical significance of the interaction, the Cox proportional hazards model is
where c s is the study-specific estimate for the cross-product term of the potential effect modifier variable (m is ) times the exposure variable (x is ) and n s is the study-specific main effect of the effect modifier. The study-specific estimatesĉ s are then pooled across studies, and the p value corresponding to the test for interaction (H 0 : c ¼ 0) is obtained from a Wald test based upon the pooledĉ. We use a mixed-effects meta-regression model (70) to test for effect modification when the exposure-disease association is nonlinear, when the potential effect modifier is a polytomous nominal variable, or when effect modification can be assessed only between studies. As an example, consider the test for effect modification by gender. The model here is a slightly modified version of equation 2:
for s ¼ 1, . . ., S, where s is the study number, theb s are the estimated study-specific exposure-disease effects, b 0 is the log relative risk for the exposure in the reference level of the modifier (here, men), b 1 is the difference in the log relative risks between the reference level and each of the other levels (here, between genders), z s ¼ 1 if study s is carried out among women and z s ¼ 0 if it is carried out among men, b s are the study-specific random effects, and e s are the within-study sampling errors. The Wald test statistic based on the estimateb 1 and its standard error is used to test the null hypothesis (H 0 : b 1 ¼ 0) that there is no modification of the effect of exposure on the outcome by levels of the potential effect modifier (here, between genders).
Assessment of heterogeneity by outcome subtype
We can also evaluate whether associations differ by cancer subtype. For these analyses, we fit separate Cox proportional hazards models (equation 1) for each subtype. Occurrences of the cancer under study that are of a different subtype are censored at their date of diagnosis. The relative risks obtained for each subtype that are estimated in this way are asymptotically uncorrelated (71) (72) (73) . In addition, because these estimates are asymptotically normally distributed with variances given by the square of their respective estimated standard errors, any linear combination of the different estimates is normally distributed, and it follows from the Cramer-Wald device (74) that the multivariate vector obtained by combining all of the competing risk estimates is multivariate normal. The corresponding variances are in the diagonal of the covariance matrix, and zeroes are in the off-diagonal. To test the null hypothesis that there is no difference in the pooled exposure-disease parameters among the subtypes, we use a contrast test (75) . For example, to test whether the pooled exposure-disease parameters differed among three subtypes, we would use the test statistic Z 2 given by
where C is a contrast matrix whose first and second rows are (1, ÿ1, 0) and (1, 0, ÿ1),b is the vector of the pooled estimates of the exposure-disease association for the different subtypes, andR is its estimated covariance matrix. The Z 2 statistic in this example has an approximate v 2 distribution with 2 df (defined by the number of different subtypes minus 1) (75) . These methods can also be used to construct tests for heterogeneity of effects between any set of cancers or other outcomes.
Measurement error correction
As with most exposures, measurement of dietary variables is not free from error. Measurement error in dietary data derives from normal within-person variation in intakes over time (76) and from errors associated with self-reports (77) . Therefore, the relative risks will be biased, usually towards the null, but can be biased in either direction when there is also error in measuring confounding variables (78) . One can use the validation data from each study to regress the ''gold standard'' (or an unbiased estimate of the gold standard, an ''alloyed'' gold standard (79)) on the errorprone measurement and confounding variables to obtain a correction factor. This correction factor can then be used to calibrate the uncorrected estimates of the exposure effect of interest obtained from logistic and Cox regression models (77, 79, 80) . If the errors in the alloyed gold standard are correlated with the errors in the usual measure of dietary intake, the regression calibration method for measurement error correction will remove some, but not all, of the bias in the effect estimate (81) . However, it appears that energy adjustment removes much of the bias in this method due to correlated errors for at least some dietary variables (e.g., protein) (82, 83) . To remove the remaining bias, an additional method of assessment of intake is needed, such as a biomarker (81) .
In the measurement error correction analyses, for each study, the true intake of the particular nutrient being evaluated or an unbiased estimate of the true intake (e.g., intakes calculated from several dietary records or 24-hour recalls) is regressed on the surrogate measurement of that nutrient (calculated from the food frequency questionnaire) to obtain the coefficientk s and its estimated standard error. We then derive the corrected estimate of the log relative risk aŝ b s =k s ; whereb s is the uncorrected estimated effect in each study from a logistic regression or Cox proportional hazards regression analysis. The standard error ofb s =k s is derived using the delta method (84) . One can simultaneously correct for the error in several covariates in all point estimates and their standard errors using a multivariate extension of measurement error correction (79, 85) . The corrected coefficient estimates are then pooled into a summary estimate. If a study has poor validity of nutrient measurements, its variance will be large, and the study will thus have little weight when the study-specific results are pooled. In addition, under the required assumption that the dietary records and 24-hour recalls provide an unbiased estimate of nutrient intake (even if subject to random error), this approach calibrates the estimated relative risks to a common unit of measurement across studies, thereby adjusting for systematic errors due to differences in the food frequency questionnaires used in the various studies.
STRENGTHS AND LIMITATIONS
The Pooling Project of Prospective Studies of Diet and Cancer provides a large collection of data in which multiple diet-and-cancer hypotheses can be examined with greater statistical power than is available in any one study. Each study included in the Pooling Project is a prospective cohort study in which diet was assessed prior to development of disease, thereby limiting recall and selection biases. In the Pooling Project, we standardize the modeling of the exposure and confounding variables to remove potential sources of noncomparability and heterogeneity that occur in the published literature. We are able to examine associations over a wide range of intakes with greater precision than in the individual studies, because of the larger sample size and the different diets consumed across the populations. In addition, we can evaluate whether associations are modified by other factors and whether associations differ among cancer subtypes. Because inclusion of an individual study in a particular analysis is not dependent on whether those investigators have published findings on that association, publication bias does not affect our pooled analyses-as opposed to meta-analyses of the published literature, for which approximately half of the results may have some indication of publication bias (86) . Finally, results from these pooled analyses may assist epidemiologists and other health professionals in synthesizing the vast amount of published data on specific diet-cancer associations.
A limitation of the Pooling Project is that it was planned retrospectively. Thus, there are differences in how the included studies were designed and implemented. First, the studies comprise populations from different geographic regions with different age ranges and education levels. However, these differences in study population characteristics may be considered a strength, particularly if the results are consistent across studies. Second, the dietary assessment methods used vary across studies, which may lead to artifactual differences in estimated intakes across studies, in addition to any true between-population differences in intakes. However, it is also possible that validity is enhanced by the use of study-specific questionnaires, since they may be tailored for use in each component study. Some heterogeneity of assessment instruments cannot be avoided, even in prospectively planned pooled studies-if, for instance, the language spoken and the foods consumed differ between populations. Another limitation of the Pooling Project is that only current diet at baseline was measured in most of the studies; thus, we cannot examine the effects of dietary changes occurring during follow-up or assess associations with diet at younger ages. There may be differential control for confounding across studies because the nondietary variables that were measured varied across studies, although many important potential confounders were measured in most studies. In addition, by standardizing which confounding variables are included in the multivariate models and their categorization, we have minimized between-studies heterogeneity resulting from how potentially confounding variables were modeled. A final restriction is our inability to examine effect modification by race and ethnicity, because the Pooling Project currently includes studies from only North America and Europe and a predominantly Caucasian population; however, as studies from other regions and with persons of different ethnicities become eligible to join the Pooling Project, the ethnic composition of the Pooling Project will expand.
Despite these limitations and restrictions, the data compiled in the Pooling Project are a valuable resource for prospectively investigating associations between diet and cancer, particularly for population subgroups, less common cancers, and specific cancer subtypes. In our analyses, we use standardized criteria to define each variable in order to reduce potential sources of between-studies heterogeneity. We then evaluate whether associations are consistent across different study populations. Finally, the methods that we use in the Pooling Project may be modified to pool data from both case-control and cohort studies to examine associations between dietary and nondietary risk factors and disease.
